The research was a collaboration between the University of Oxford, the University of Exeter and Chiddenbrook Surgery, Crediton, researchers investigated
Tag: Bone pain
Fulphila for reducing duration of febrile neutropenia
Fulphila has been approved to reduce the duration of febrile neutropenia (fever or other signs of infection with a low
Crysvita for X-Linked Hypophosphatemia
The U.S. Food and Drug Administration today approved Crysvita (burosumab), the first drug approved to treat adults and children ages
